Investigator Site 139 — Little Rock, Arkansas

Investigator Site 139 is a clinical research site located in Little Rock, Arkansas, United States 72202.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator Site 139 has participated in 2 clinical trials.

Therapeutic areas: Exocrine Pancreatic Insufficiency, Cystic Fibrosis.

Sponsors: Anthera Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 139?

Investigator Site 139 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 139 conducted?

Investigator Site 139 has 2 clinical trials on record. Their work covers Exocrine Pancreatic Insufficiency, Cystic Fibrosis.

Is Investigator Site 139 accredited by Crixeo Health?

Investigator Site 139 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 139?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.